Market Research Reports
49 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Maria Robert
Scoop.it!

Siena Biotech S.p.A. - Product Pipeline Review - 2014 : ReportsnReports

Siena Biotech S.p.A. - Product Pipeline Review - 2014 : ReportsnReports | Market Research Reports | Scoop.it

Siena Biotech S.p.A. - Product Pipeline Review - 2014


Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Siena Biotech S.p.A. Market in subject line and your contact details.

Siena Biotech S.p.A. Product Pipeline Review 2014', provides an overview of the Siena Biotech S.p.A.'s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of Siena Biotech S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=288312.

 

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Unified Threat Management Market by Appliance (Hardware, Software, Virtual), Services, Managed UTM, Distribution Channel (Direct, VAR’s, Distributors), Organization Size (SOHO, SMB, Enterprises) - ...

Unified Threat Management Market by Appliance (Hardware, Software, Virtual), Services, Managed UTM, Distribution Channel (Direct, VAR’s, Distributors), Organization Size (SOHO, SMB, Enterprises) - ... | Market Research Reports | Scoop.it
Unified Threat Management Market by Appliance (Hardware, Software, Virtual), Services, Managed UTM, Distribution Channel (Direct, VAR’s, Distributors), Organization Size (SOHO, SMB, Enterprises) - Global Market Forecasts & Analysis (2014 - 2019) Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Unified Threat Management Market in subject line and your contact details. Unified Threat Management (UTM) is defined as a solution that integrates multiple point security technologies into a single network appliance. These solutions are generally easy to use and are cost-effective, which in turn delivers high value to end users in terms of space and energy efficiency. These appliances are also used for streamlining of management processes, reducing administrative overhead, and in maintenance burden. UTM market comprises mainly of appliances and services. Appliances include hardware, software and virtual. Hardware appliances accounts for the highest market share. On the other hand, software and virtual appliances are also expected to grow significantly. The services segment includes support and maintenance, and managed UTM as sub-segments. Out of this, support and maintenance accounts for the major market share. Few high growth markets include:- • Small Offices Home Offices (SOHO): SOHO would rapidly adopt UTM solutions due to its extensive benefits such as low cost, ease of deployment, and configuration capabilities. • Virtual Appliances: This market is anticipated to grow with extensive integration of appliances with the cloud. • Banking and Financial Institutions (BFSI): BFSI is one of the major end users of UTM solutions. Over the period of time, it is expected that BFSI would leverage the maximum benefits from UTM solutions. • Distributors: The distributors hold a significant position in the UTM market. Distributors nearly control 65-70% of the whole market. The key playing fields are virtual appliances in the UTM appliances market. Virtual appliances are widely adopted with integration of cloud and managed services. These appliances offer network security to virtual data centers. These appliances provide a complete web and email security solution that protects SMB’s from new malware, malicious websites, phishing attacks, botnets, and other threats. Analyst expects that the BFSI vertical will account for the largest market share throughout the forecast period. However, there are few revenue pockets, namely government and utilities, healthcare, retail, and telecom and IT that will witness significant growth in this period. The rise in the advanced threats such as SQL injection, cross site scripting, and sophisticated DDOS attacks which have targeted the SMB’s across the world, has led to the increase in demand for next generation firewalls, Intrusion Prevention System (IPS), and web security gateway. This demand enforces the organizations to replace one’s existing network security solutions with the UTM products. The UTM products are widely adopted by the SMB’s, especially in the regions of North America (NA) and Western Europe, due to the product aging of its existing network security solutions. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=281587.
more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Global Choroidal Neovascularization (CNV) Market 2014-2018 : ReportsnReports

Global Choroidal Neovascularization (CNV) Market 2014-2018 : ReportsnReports | Market Research Reports | Scoop.it

Global Choroidal Neovascularization (CNV) Market 2014-2018

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Choroidal Neovascularization (CNV) Market in subject line and your contact details.


The current competition in the Global CNV market is strong as the available treatment options and marketed products have been successful in meeting the market requirement, while treating the underlying cause of the disease. The current market drugs include Lucentis, approved for CNV associated with wet AMD; Macugen, approved for CNV associated with wet AMD; and Visudyne, approved for CNV associated with wet AMD, presumed ocular histoplasmosis, and pathologic myopia. Apart from these, Avastin, which is currently used as an off-label drug has gradually captured a major share of the market. In addition, the CNV pipeline seems to be promising with various molecules in the development phase. These products are expected to meet the unmet needs in the market and will provide physicians with a wider choice in treating CNV.


According to the report, the Global CNV market is driven by several factors, of which high patient and physician satisfaction is one of the major drivers. High patient and physician satisfaction has resulted in increased demand for CNV treatment therapies.

CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the known causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently no medical treatment for this disease, this abnormal growth can easily lead to impairment of sight or complete loss of vision.

 

Analysts forecast the Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=288376.

 

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Cloud Database and DBaaS Market by Databases (SQL, Nosql), Software (Database Application Builder, Data Scaling and Replication, Back-Up and Recovery, Database Encryption), Deployment Models (Iaas,...

Cloud Database and DBaaS Market by Databases (SQL, Nosql), Software (Database Application Builder, Data Scaling and Replication, Back-Up and Recovery, Database Encryption), Deployment Models (Iaas,... | Market Research Reports | Scoop.it

Cloud Database and DBaaS Market by Databases (SQL, Nosql), Software (Database Application Builder, Data Scaling and Replication, Back-Up and Recovery, Database Encryption), Deployment Models (Iaas, Paas, Dbaas) and Service Models (Public Cloud, Private Cloud, Virtual Private Cloud, Hybrid Cloud) & Organization Size (Small And Medium, Large) - Global Advancements, Market Forecasts and Analysis (2014-2019)


Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Cloud Database and DBaaS Market in subject line and your contact details.

Emergence of innovative database storage offerings such as NoSQL, SQL, public cloud, private cloud, hybrid cloud, and virtual private cloud are pushing the growth of cloud database and Database as a Service (DBaaS) market. Small and medium business are rapidly adopting cloud-based database management services to reduce cost and IT complexities compared to large enterprises, thereby pushing the market growth. However, large enterprises also have huge potential for an aggressive adoption in the future.

 

The Cloud database and DBaaS market report consists of revenues from software, services, deployment models, and service models required for storing database in the cloud. The overall market size consists of software solutions and services.

 

The cloud database and DBaaS market is segmented by types of software solution into database application builder, data scaling and replication, backup and recovery, database encryption, and others. These software solutions fulfill the customer requirements in every aspect.  These software solutions are usually implemented by considering the security and importance of the database. Small and medium businesses along with large enterprises are strategically analyzing the cloud database and DBaaS solutions for their existing huge volume of databases as well as for new databases which will be generated.

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=280808.


The cloud database and DBaaS model is segmented into databases, services, and different deployment and service models. These segments are being deployed for Banking, Financial Services, and Insurance (BFSI), hospitality, government, healthcare and life sciences, academics, and telecommunications. The cloud database and DBaaS market report forecasts and analyzes the solution uptake for these end users.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Complete 2013-14 (iPSC) Induced Pluripotent Stem Cells Industry Report : ReportsnReports

Complete 2013-14 (iPSC) Induced Pluripotent Stem Cells Industry Report : ReportsnReports | Market Research Reports | Scoop.it

Complete 2013-14 Induced Pluripotent Stem Cell Industry Report

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Induced Pluripotent Stem Cell Market in subject line and your contact details.

Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are examples of clinical applications in which stem cells could offer benefits in halting or even reversing damage.

 

Complete report is spread across 127 pages is available @ http://www.reportsnreports.com/reports/206575-complete-2012-13-induced-pluripotent-stem-cell-industry-report.html.


Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which creates narrow options for use. Thus, induced pluripotent stem cells (iPSC cells) represent a promising combination of adult and embryonic stem cell characteristics.

 

Induced Pluripotent Stem Cells Discovery:
Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSC cells). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells at Kyoto University in Japan was the first instance in which there was successful generation of the iPSC. In 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells.

While there has been continued excitement at the prospect of what such artificially re-manufactured cells could contribute to medical advances, there have also been issues along the way. By 2010, there were a number of private companies that were ready to capitalize on the breakthrough technology that iPSC represent. One such company, Advanced Cell Technology in Worcester, Massachusetts, discovered several problematic issues while conducting experiments for the purpose of applying for U.S. Food and Drug Administration approval to use Induced Pluripotent Stem Cells in therapeutic applications. Concerns such as premature cell death, mutation into cancer cells, and low proliferation rates were some of the problems that surfaced.

 

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=206575.


Research Advances:
Continued research and experimentation has resulted in numerous advances over the last few years. In one example, the University of Michigan announced in “Circulation Research” (2012) that they had developed innovative methods for use of induced pluripotent stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment quickly fueled other research into the use of iPSC cells for the reversal and repair of diseased heart tissue.

Similar advances will continue to be perfected for use of reprogrammed adult cells in the treatment of other diseases and disorders. Original techniques for iPSC cells production, such as viral induced transcription processes, are being replaced with newer technologies as private industries join with the scientific community to develop safe and efficient methods of Induced Pluripotent Stem Cells production. With sustained research and experimentation, established guidelines for effective production of iPSC cells will be commonplace.

In summary, induced pluripotent stem cells represent a promising tool for use in the reversal and repair of many previously incurable diseases.

 

Market Metrics – iPSC cells Research Products:
For this reason a large and thriving research products market has grown into existence for the cell type. The number of iPSC cells research products sold worldwide has been growing at an annual rate of 14.7% for the past five years. In addition, 22% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project. It is clear that iPSCs are a vital research trend within the scientific community.

 

A distinctive feature of this “Induced Pluripotent Stem Cells Market (iPSC cells)” report is an end-user survey of 274 researchers (131 U.S. / 143 International) that identify as having induced pluripotent stem cells as their core research focus. These survey findings reveal iPSC cells researcher needs, technical preferences, key factors influencing buying decisions, and more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

Request for Sample @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=206575.

 

Key Findings for Induced Pluripotent Stem Cells Market (iPSC cells) Include:
•    Charts, Timelines, and Financials for the iPSC cells Research Product Market
•    Trends for induced pluripotent stem cells  (iPSC cells) Grants, Scientific Publications, and Patents
•    5-Year Market Size Projections (2014-2018)
•    Competitive Environment Analysis, including Market Share by Competitor
•    Preferred Species for iPSC cells Research
•    iPSC cells Product Categories (Breakdown of Market Share by Each)
•    Consumer Behavioral Patterns and Preferred Providers
•    Crucial Trends and Unmet Market Needs
•    “Tested Sentences” for Selling to iPSC cells Scientists
•    Breakdown of the Marketing Methods Used by Industry Participants
•    End-User Survey of iPSC cells Researchers (131 U.S. / 143 International)

In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC cells  products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the marketplace, and take advantage of crucial iPSC cells market trends. Claim this report Induced Pluripotent Stem Cells market now to profit from this expanding market - or your competition will.

 

Table Of Contents

    I.        Abstract  II.        iPSC cells BackgroundIII.        Timeline                IV.        iPSC cells Market Research Applications   V.        Characterization Of iPSC cells Research Advances VI.        Companies Selling iPSC cells Research ProductsVII.        Types Of Induced Pluripotent Stem Cells Research ProductsVIII.        Companies Developing iPSC cells Therapies IX.        Strategic Collaborations For Development Of Induced Pluripotent Stem Cells Products   X.        iPSC cells Market Trend Analysis XI.        Induced Pluripotent Stem Cells Market SizeXII.        Scientist Panel: Induced Pluripotent Stem Cells Detailed End-User SurveyXIII.        Strategies For Accessing The MarketplaceXIV.        Conclusions

 

Browse Complete Table of Content @ http://www.reportsnreports.com/reports/206575-complete-2012-13-induced-pluripotent-stem-cell-industry-report.html.


Explore Report on Stem Cell Market.

 

 

Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Complete 2013-14 Induced Pluripotent Stem Cell Industry Report” OR for any other market research and intelligence needs you may have for your business.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Tuberculosis Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape :...

Tuberculosis Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape :... | Market Research Reports | Scoop.it

Tuberculosis Testing Market 2014 : US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Tuberculosis Testing Market in subject line and your contact details.

The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

HospitalsCommercial/Private LabsPhysician OfficesPublic Health Labs

 

Complete report is spread across 208 pages is available @ http://www.reportsnreports.com/reports/274000-tuberculosis-testing-market-2014-us-europe-france-germany-italy-spain-uk-japan-emerging-opportunities-supplier-shares-country-forecasts-innovative-technologies-competitive-landscape.html.

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Tuberculosis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns

Table of Contents

I. Introduction

II. TUBERCULOSIS Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs

D. Emerging Diagnostic Technologies

1. Molecular Diagnostics, 2. Monoclonal Antibodies, 3. Immunoassays, 4. Differential Light Scattering, 5. Information Technology, 6. Artificial Intelligence, 7. Liposomes,8. Flow Cytometry, 9. Chromatography,10. Diagnostic Imaging,11. Gel Microdroplets,12. Other

 

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

 

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=274000.


X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers

6. Major Types of Distributors
7. Market Segmentation

 

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

 

Request for Sample @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=274000.


XII. Competitive Assessments
Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix, DiaSorin, Eiken Chemical, Enzo Biochem, Fujirebio, Gen-Probe, Hologic, ID Biomedical, Innogenetics/Solvay, Kreatech, Life Technology, Lonza, Nanogen/Elitech, Novartis Diagnostics Ortho-Clinical Diagnostics Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Takara Bio, Thermo Fisher, Wallac, Wako


List of Tables

Major Companies Developing or Marketing Tuberculosis Tests
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Germany Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Italy Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Japan Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Japan Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=274000.


Explore Report on Infectious Disease Testing Market.


Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Tuberculosis Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape” report OR for any other market research and intelligence needs you may have for your business.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Global Diabetes Devices Market Trends & Opportunities Analyzed in New Report

Trends and Opportunities in the Diabetes Care Market report highlighting and analysing the market leaders, competing products and new developments across a wide range of technology areas.

Maria Robert's insight:

Trends and Opportunities in the Diabetes Care Market

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Diabetes Care Market in subject line and your contact details.


The global market for diabetes devices was estimated to be worth US$ 12.2 billion in 2012. And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets.

In geographical terms, the US market dominates this sector, with Europe and other developed markets close behind. However, while these regions are experiencing pricing pressures and slower than usual sales volumes as a result of the economic downturn and government reductions in healthcare spending, there has been strong demand for SMBG (Self-monitoring blood glucose) and manual insulin delivery products in emerging and developing nations.

 

Complete report is spread across 252 pages is available @ http://www.reportsnreports.com/reports/273309-trends-and-opportunities-in-the-diabetes-care-market.html.


This new report provides a complete and comprehensive review of the current diabetes device market, highlighting and analyzing the market leaders, competing products and new developments across a wide range of technology areas. Furthermore, this report also acts as a diabetes device manufacturer directory detailing each company's recent key events in the diabetes sector and providing granular financial data (where available).

 

What this report contains:

Executive SummaryMarket overview covering the global diabetes market, the competitive environment and the growth drivers, restraints and future opportunitiesMarket dynamics, detailed breakdown of key leading products, competing products and products in development for Diabetes Monitoring Products and Insulin Delivery ProductsCurrent products and products in development within Combined CGM-Insulin Pump Systems technologiesCurrent research and development for Artificial Pancreas TechnologiesDiabetes device company directory and company profiles for market-leading companies, detailing recent key events and important financial data

 

 

The Diabetes report is the foolproof business resource for any industry executive that needs to fully understand the current players and future prospects within the global diabetes market. The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with the answers.

 

Diabetes Device Company Directory

Abbott Laboratories, DexCom, Arkray, MyCareTeam, MyCareTeam, DexCom , Animas, Insulet , LifeScan, Eli Lilly and Company , Abbott , Ypsomed , GlaxoSmithKline , Flextronics International , Johnson & Johnson .       

  

List of Tables
Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million)   6
Global Diabetes Market by Product Type, 2006-2012 (US$ million)   14
Global Diabetes Market Growth Rates by Product Type, 2006-2011 (%)   15
Key Companies’ Diabetes Care Sales, 2005-2012 (US$ million)   18
Non-US Companies’ Diabetes Sales in Reported Currency, 2006-2012 (million)   19
Leading Companies’ International Diabetes Care Sales, 2006-2012 (US$ million)   19
Key Companies’ US Diabetes Care Sales, 2006-2012 (US$ million)   19
Key Companies: Market Presence & Position by Product Area, 2012   21
Key Companies: Current & Future Potential Market Presence by Product Area   22
Global Diabetes Market Forecast by Product Type, 2012-2018E (US$ million)   31
Global Diabetes Market Forecast Growth Rates by Product, 2012-2018E (%)   31
Overview: Glucose Monitoring Products   33
Public Companies’ Glucose Monitoring Sales, 2006-2012 (US$ million)   35
SMBG Market by Major Geographic Region, 2011-2012 (US$ million)   40
Summary: SMBG Growth Drivers, Restraints & Opportunities   44
Key Companies’ SMBG Sales, 2006-2012 (US$ million)   45
Competing Self-Testing Blood Glucose Monitoring Products   57
Summary: CGM Benefits, Challenges & Opportunities   74
Companies’ CGM Sales, 2006-2012 (US$ million)   75
Insulin Delivery Market by Product Type 2005-2012 (US$ million)   102
Key Companies’ Insulin Delivery Sales, 2006-2012 (US$ million)   104
Summary: Insulin Delivery Market Growth Drivers, Restraints & Opportunities   105
Insulin Delivery Market Forecast by Product Type 2012-2018E (US$ million)   105
Insulin Pump Market: Growth Drivers, Restraints & Opportunities   115
Key Companies’ Insulin Pump Sales, 2006-2012 (US$ million)   122

 

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=273309.


List of Charts
Fig   1: Diabetes Prevalence by Geographic Region, 2011-2030   6
Fig   2: Diabetes Device Market by Major Product Category, 2012   11
Fig   3: Percentage of US Diabetes Patients by Treatment Type, 2007-2009   11

Fig   4: Diabetes Device Market by Product Type, 2012   13
Fig   5: Global Diabetes Device Market, 2005-2012 (US$ billion)   13
Fig   6: Global Diabetes Market By Product Type, 2006-2012 (US$ billion)   15
Fig   7: Global Diabetes Device Market by Region, 2012   16
Fig   8: US Market by Product Type, 2012   16
Fig   9: International Market by Product Type, 2012   17

Fig   10: Diabetes Device Market Share by Company, 2012   18
Fig   11: Diabetes Device Market by Product, 2018E   31
Fig   12: Global Glucose Monitoring Market, 2005-2012 (US$ billion)   34
Fig   13: Global Glucose Monitoring Market Growth, 2005-2012 (%)   35
Fig   14: Glucose Monitoring Market by Product Type, 2012   35
Fig   15: Glucose Monitoring Market Share by Company, 2012   36
Fig   16: Global SMBG Market, 2005-2012 (US$ million)   38
Fig   17: Global SMBG Market Growth Rates, 2005-2012 (%)   38
Fig   18: SMBG Market by Product Type, 2012   39
Fig   19: SMBG Market by Region, 2012   40
Fig   20: Global SMBG Market, 2012-2018E (US$ billion)   44
Fig   21: Global SMBG Market Growth Rates, 2012-2018E (%)   44
Fig   22: SMBG Market Share by Company, 2012   46
Fig   23: United States SMBG Market Share by Company, 2012   46
Fig   24: SMBG International Market Share by Company, 2012   46
Fig   25: Global CGM Market, 2006-2012 (US$ million)   69
Fig   26: Percentage of CGM Sales Volumes by Hardware & Consumables, 2012   70
Fig   27: CGM Market by Region, 2012   70
Fig   28: Global CGM Market Forecast, 2012-2018E (US$ million)   73
Fig   29: Global CGM Market Growth Rates, 2012-2018E (%)   73
Fig   30: Global CGM Market Shares by Company, 2012   75

 

Inquiry Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=273309


Fig   31: US CGM Market Shares by Company, 2012   75
Fig   32: International CGM Market Shares by Company, 2012   76
Fig   33: Percentage of US Diabetes Patients by Treatment Type, 2007-2009   102
Fig   34: Global Insulin Delivery Market, 2007-2012 (US$ billion)   103
Fig   35: Global Insulin Delivery Market Growth Rates, 2006-2012 (%)   103
Fig   36: Percentage of Insulin Delivery Market by Product Type, 2012   103
Fig   37: Global Insulin Delivery Market Estimated Growth Rates, 2012-2018E (%)   105

Fig   38: Estimated Insulin Delivery Market by Product Type, 2018E   106
Fig   39: Percentage of Novo Nordisk’s Insulin Sold in Pens by Region, 2011-2012   107
Fig   40: Manual Insulin Delivery Market by Geographic Region, 2012   107
Fig   41: Global Insulin Pen Market: Disposable vs Reusable Pens, 2012   108
Fig   42: Global Insulin Pump Market, 2005-2012 (US$ million)   116
Fig   43: Global Insulin Pump Market Growth Rates, 2006-2012 (%)   117
Fig   44: Insulin Pump Market by Product, 2012   117
Fig   45: Insulin Pump Market by Region, 2012   118
Fig   46: Insulin Pump Adoption Rates for Type 1 Diabetes Patients by Key Country, 2010 (%)   119
Fig   47: Insulin Pump Market Shares, 2012   122
Fig   48: Global Insulin Pump Market Forecast, 2012-2018E (US$ million)   123
Fig   49: Global Insulin Pump Market Estimated Growth Rates, 2012-2018E (%)   123
Fig   50: Percentage of Abbott Diabetes Care Revenue by Region, 2012   172
Fig   51: Percentage of BD Diabetes Care’s Revenue by Region, 2012   184
Fig   52: J&J Diabetes Care Sales by Region, 2012   208
Fig   53: J&J Diabetes Care Sales, 2004-2012 (US$ million)   208
Fig   54: Medtronic Diabetes Revenue, Fiscal 2005-2013 (US$ million)   219
Fig   55: Medtronic Diabetes Revenue by Region, Fiscal 2013   219
Fig   56: Roche Diabetes Care - Revenue by Product Line, 2012   229
Fig   57: Roche Diabetes Care - Revenue by Region, 2012   229
Fig   58: Ypsomed - Revenue by Business Segment, Fiscal 2012/13   237
Fig   59: Ypsomed - Revenue by Geographic Location, Fiscal 2012/13   237

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=273309.


Explore more reports on Diabetes Market.


Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Trends and Opportunities in the Diabetes Care Market” report OR for any other market research and intelligence needs you may have for your business.

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Global Policy Management Software Market 2014-2018 : ReportsnReports

Global Policy Management Software Market 2014-2018 : ReportsnReports | Market Research Reports | Scoop.it

Global Policy Management Software Market 2014-2018

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Policy Management Software Market in subject line and your contact details.


LTE-A is the advanced version of LTE, and it can deliver speeds of up to 150 Mbps, which is double the maximum speed promised by LTE and 10 times faster than 3G technology. Yota, a Russian mobile broadband service provider, launched the first LTE-A network in the country in October 2012. However, SK Telecom was the first operator to roll out the technology commercially with the compatible handset in June 2013. The operators witnessed wide adoption of LTE-A with over 150,000 users, around 0.6 percent of its total subscriber base. The US was expected to have more than five LTE-A supported networks by 2013. LTE subscribers in North America will gradually shift to LTE-A, accounting for more than 50 percent of the total LTE connections in the region. Consequently, the adoption of smartphones supporting LTE-A is expected to be on the rise during the forecast period.


Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=288380.

 

According to the report, a need for bandwidth management is driving the market as network congestion and poor network performance are the major concerns for most of the organizations and network operators worldwide. In Europe, network operators observed that blocking of Voice-over-Internet Protocol and peer-to-peer traffic is a common cause for network congestion. Therefore, to improve network bandwidth, organizations are increasingly adopting policy management software.

Policy management and control software is a type of centralized software that performs functions such as subscriber authentication and access control, customer self-provisioning, service creation and deployment for carrier network administrators, and communication of subscriber profile data to business support systems and operations support systems. Over the last few years, policy servers have evolved to handle not only static data such as subscriber, network, and device information, but also dynamic session-based data such as the network bandwidth requirements of an application and which network routes should be used to deliver the best quality of service.

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=288380.

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Global Mechanical Ventilators Market 2014-2018 : ReportsnReports

Global Mechanical Ventilators Market 2014-2018 : ReportsnReports | Market Research Reports | Scoop.it

Global Mechanical Ventilators Market 2014-2018


Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Mechanical Ventilators Market in subject line and your contact details.


The Healthcare industry witnessed a paradigm shift from providing hospital care to home healthcare over the last decade. This has led to the development and adoption of HMV systems to improve the patient's quality of life. For instance, Respironics Trilogy 202 ventilator by Phillips Healthcare offers several ventilation modes and breathing circuit configurations to be used at home. Patients in need of continual or life-long ventilator support are considered a cost burden on hospital administration. Hence, to reduce hospital costs, there has been a growing trend of shifting such patients to non-hospital settings.


According to the report, the Global Mechanical Ventilators market has several growth drivers, of which the increasing aging population is one of the major drivers. The aging population is more susceptible to developing respiratory diseases. The growing number of aged patients in ICUs has raised the demand for mechanical ventilators.

 

A mechanical ventilator is a life-supporting medical device used to assist or replace a patient's breathing. A mechanical ventilation is generally the last resort for a patient who is having difficulty breathing and cannot maintain adequate oxygenation to maintain life. Patients with respiratory disorders such as COPD may require the need of mechanical ventilators. Mechanical ventilators can be positive pressure type and negative pressure type depending on the method of delivery of oxygen into the lungs by the ventilator. Positive pressure mechanical ventilators involve air (or another gas mix) being pushed into the trachea of the patient while with negative pressure mechanical ventilators the air is sucked inside. In general, mechanical ventilators are connected through an endotracheal tube that is placed in the windpipe of the patient (known as invasive ventilators). Some of the latest mechanical ventilators assist breathing through a mask or mouthpiece (non-invasive ventilators).

Analysts forecast the Global Mechanical Ventilators market will grow at a CAGR of 6.78 percent over the period 2013-2018.

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=288379.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Business Process as A Service (BPaaS) Market & Cloud BPM Market By Process Outsourcing (Sales, Finance and Accounting, Human Resources, Marketing, Operations) Forecast & Analysis

Business Process as A Service (BPaaS) Market & Cloud BPM Market By Process Outsourcing (Sales, Finance and Accounting, Human Resources, Marketing, Operations) Forecast & Analysis | Market Research Reports | Scoop.it

Business Process as A Service (BPaaS) Market & Cloud BPM Market By Process Outsourcing (Sales, Finance and Accounting, Human Resources, Marketing, Operations) – Global Advancements, Opportunity Roadmaps, Market Forecast and Analysis (2013 - 2018)

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Business Process as A Service (BPaaS) Market & Cloud BPM Market in subject line and your contact details.


Business Process as a Service (BPaaS) and Cloud BPM refers to a business process layer on top of cloud services such as Software as a Service (SaaS), Platform as a Service (PaaS) and Infrastructure as a Service (IaaS). It encompasses business process services for horizontal as well as vertical business processes through a feature-rich platform for delivering automated business outcomes. These solutions provide enterprises with several advantages including increased transparency in the business processes, virtualized workplaces, flexibility, informed decisions, and accelerated performance along with simplified operations.

To increase the cost effectiveness of a process execution and to avoid vendor locking, the Business Process as a Service and Cloud BPM solutions are being adopted to create a network amongst employees, partners, distributors,suppliers and others in the business ecosphere to deliver high value process outcomes. While enterprises across the globe are looking forward to breed the business process services into their current work scenarios, BPaaS and Cloud BPM providers look forward to gain better competitive advantage in the emerging market by creating multi-process platform that provides a complete solution for all business processes.

 

The need for increasing the agility of a business process, along with cost control measures is playing a cardinal role in shaping the future of Business Process as a Service and Cloud BPM market. Although the adoption of these solutions is relatively slow due to cautious approach of the top management and compliance concerns; these solutions are expected to enjoy enduring growth and have a pervasive existence across all major verticals, owing to the growing demand for automation and virtualization of workplace. These solutions are well-positioned to provide solution for globally spread businesses, despite different organizational structures and business process needs.

 

Analyst further expects that the integration of Business Process as a Service and Cloud BPM solutions within the existing organizational framework will further amplify the growth of businesses, while ensuring the compliance and regulatory standards. This research report categorizes the global market for BPaaS and Cloud BPM to forecast the revenues and analyze the trends for the business processes such as sales, finance and accounting, human resources, marketing and operations in each of the following sub-markets:

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=253811.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Europe 2G, 3G & 4G Wireless Subscriptions, Spectrum Licensing, Ownership & Infrastructure Contracts Database: 2014 – 2020

Europe 2G, 3G & 4G Wireless Subscriptions, Spectrum Licensing, Ownership & Infrastructure Contracts Database: 2014 – 2020 | Market Research Reports | Scoop.it

Europe 2G, 3G & 4G Wireless Subscriptions, Spectrum Licensing, Ownership & Infrastructure Contracts Database: 2014 – 2020

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Europe 2G, 3G & 4G Wireless Market in subject line and your contact details.

Covering over 59 countries and 220 wireless carriers in Europe, the "Europe 2G, 3G & 4G Wireless Subscriptions, Spectrum Licensing, Ownership & Infrastructure Contracts Database: 2014 2020" database tracks mobile network subscriptions, penetration, spectrum licensing, mobile infrastructure contracts and network ownership data. The database is delivered as a Microsoft excel file.

Contents: This product comprises the following databases delivered in a single excel file:

Mobile Network Subscriptions Database

Number of mobile network subscriptions (2011 2020) by:

RegionCountryMobile network operatorAir interface technology*

 

Mobile Penetration Database

Population data (2011 2020) by:

RegionCountry

 

Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=288166.


Mobile penetration % data (2011 2020) by:

RegionCountry

Mobile Spectrum Licensing Database

Operator Spectrum data by:

RegionCountry Mobile network operatorAir interface technology*FrequencyBandwidth

 

Mobile Network Infrastructure Contracts Database

Mobile network infrastructure contracts by:

RegionCountryMobile network operatorAir interface technology*Infrastructure vendor/supplierContract value ($ Million)Contract dateEquipment type

 

Mobile Network Ownership Database

Mobile network ownership data by:

RegionCountryMobile network operatorParent companyInvestment %Status

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=288166.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

Diagnostic Imaging Market Consolidation: Who will not survive? : ReportsnReports

Diagnostic Imaging Market Consolidation: Who will not survive? : ReportsnReports | Market Research Reports | Scoop.it

Diagnostic Imaging Market Consolidation : Who will not survive?

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Diagnostic Imaging Market in subject line and your contact details.


A worldwide strategic overview of the diagnostic imaging market, including:

Estimates of the market size and growth.Sales forecasts by geographic region and modality.Review of the U.S. and international technological, regulatory, economic, demographic and social trends with potentially significant impact on the diagnostic imaging industry during the next five years.Analysis of major geographic regions, including North America, Europe, Japan and Latin America.Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies.

The companies analyzed in the report include Analogic, Esaote, GE, Hitachi/Aloka, Hologic, Philips, Shimadzu, Siemens, and Toshiba. The company profiles include:

Business, new product development, and marketing strategies.Anticipated acquisitions, joint ventures, and divestitures.The U.S. and international sales force size in major geographic regions.Selling options, including rental plans, leasing and others.Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars,product literature, newsletters, etc.System service and support.Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

Complete report is spread across 185 pages is available @ http://www.reportsnreports.com/reports/274525-diagnostic-imaging-market-consolidation-who-will-not-survive.html.

Table Of Contents

I. Outlook
Introduction
Industry Consolidation and Diversification: A Biomodal Trend
Market Globalization
Pricing Pressures
Productivity

 

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=274525.

II. Major Geographic Regions
North America
Europe
Japan
Latin America

III. Major Modalities
X-Ray
Ultrasound
MRI
CT
Nuclear Medicine
PET
PACS

IV. Market Size and Growth

V. Leading Diagnostic Imaging Companies Strategic Directions
Business, new product development, and marketing strategies
Anticipated acquisitions, joint ventures, and divestitures

VI. Leading Diagnostic Imaging Companies Marketing Tactics
The U.S. and international sales force size in major geographic regions
Selling options, including rental plans, leasing and others
Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc
System service and support

VII. Leading Diagnostic Imaging Companies Technological Know-How
Internally developed and acquired diagnostic imaging and related technologies, Including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

 

Request for Sample @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=274525.


List of Tables

Table 1: Worldwide Diagnostic Imaging Market Estimated Sales by Geographic Region and Country
Table 2: Worldwide Diagnostic Imaging Market Estimated Sales Growth by Geographic Region and Country
Table 3: Worldwide Diagnostic Imaging Market Estimated Sales by Modality and Business

Table 4: Worldwide Diagnostic Imaging Market Estimated Sales by Modality/Business and Geographic Region
Table 5: Worldwide Diagnostic Imaging Market Estimated Sales Growth by Modality/Business

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=274525.


Explore Report on Diagnostic Imaging Market.


Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Diagnostic Imaging Market Consolidation: Who will not survive?” report OR for any other market research and intelligence needs you may have for your business.

 

more...
No comment yet.
Scooped by Maria Robert
Scoop.it!

2014 US Hospital Cancer Diagnostics Market Analyzed in New Research Report

US Hospital Cancer Diagnostics Market 2014 report analyze mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.

Maria Robert's insight:

US Hospital Cancer Diagnostics Market 2014

Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with (US Hospital Cancer Diagnostics Market) in subject line and your contact details.


This new report presents a comprehensive analysis of the US hospital cancer diagnostics market, including:

Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years.Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.Test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals.Current instrumentation technologies and feature comparison of leading analyzers.Sales and market shares of leading suppliers.Emerging diagnostic technologies and their potential market applications.Product development opportunities.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Business opportunities and strategic recommendations for suppliers.

                                                             

Complete report is spread across 567 pages is available @ http://www.reportsnreports.com/reports/272421-us-hospital-cancer-diagnostics-market-2014.html.


Table of Contents

Introduction

Worldwide Market and Technology Overview

A.   Cancer Statistics and EtiologyB.   Major Current And Emerging Cancer Diagnostic TestsC.    Instrumentation Review and Market NeedsD.   Current and Emerging TechnologiesE.    Personal Testing

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers and Risks


Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=272421.

Competitive Profiles

Abbott, AdnaGen, Applied Gene Technologies, Arca, Beckman Coulter/Danaher, Becton Dickinson, Biomedical Diagnostics, bioMerieux, BioRad, Cepheid, Correlogic Systems, Dako, Decode, Diadexus, Diagnocure, Diasorin, Eiken Chemical, Enterix, EnzBiochem, Epigenomics, Exact Sciences, Fujirebio, GenProbe, Guided Therapeutics, Hologic, Ipsogen, Kreatech, Kyowa Medex, Life Technologies, Mackay Life Sciences, Myriad Genetics, Nanogen Elitech, OncoLab, OthoClinical Diagnostics, Panacea Pharmaceuticals, Polartechnics, Polymedco, PreMD, Qiagen, Radient Pharmaceuticals, Roche, Scienion, Sequenom, Siemens Healthcare, Takara Bio, Targeted Diagnostics & Therapeutics, Tosoh, Veridex, WakPure Chemicals, Wallac/PE, Zila

List of Tables

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta2 Microglobulin Tests
Major Companies Developing or Marketing CA 153/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis

 

 

Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis

 

Request For Sample @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=272421.

 

Executive Summary Table: U.S., Hospital Cancer Diagnostic Test Volume and Sales Forecast
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Cancer Diagnostic Tests
U.S., Hospital Laboratories Performing Cancer Diagnostics Tests by Bed Size
U.S., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
U.S., Total Cancer Diagnostics Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 153/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 199 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier

 

Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=272421.

 

Explore Report on Cancer Market.

Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “US Hospital Cancer Diagnostics Market 2014” report OR for any other market research and intelligence needs you may have for your business.

more...
No comment yet.